Source:http://linkedlifedata.com/resource/pubmed/id/15268715
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2004-7-22
|
pubmed:abstractText |
It is generally accepted that the two types of neurothekeoma (myxoid type and cellular type) represent the two poles of a spectrum. This concept, however, has recently been challenged, and cellular neurothekeomas have been suggested as a separate classification and are included in the "fibrohistiocytic" category by some authors. Cellular neurothekeomas have been reported to show negative immunohistochemical staining for histiocytic markers, and PG-M1 is now considered to be the most reliable histiocytic marker.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0303-6987
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
568-72
|
pubmed:meshHeading |
pubmed-meshheading:15268715-Adult,
pubmed-meshheading:15268715-Cell Transformation, Neoplastic,
pubmed-meshheading:15268715-Female,
pubmed-meshheading:15268715-Histiocytes,
pubmed-meshheading:15268715-Humans,
pubmed-meshheading:15268715-Immunohistochemistry,
pubmed-meshheading:15268715-Neurothekeoma,
pubmed-meshheading:15268715-Scalp,
pubmed-meshheading:15268715-Skin Neoplasms,
pubmed-meshheading:15268715-Treatment Outcome,
pubmed-meshheading:15268715-Tumor Markers, Biological
|
pubmed:year |
2004
|
pubmed:articleTitle |
Cellular neurothekeoma with histiocytic differentiation.
|
pubmed:affiliation |
Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Saga University, Nabeshima 5-1-1, Saga 849-8501, Japan. misago@post.saga-med.ac.jp
|
pubmed:publicationType |
Journal Article,
Case Reports
|